HRP20090393T1 - Pharmaceutical composition for oral administration of a pyrazol-3-carboxamide derivative - Google Patents
Pharmaceutical composition for oral administration of a pyrazol-3-carboxamide derivativeInfo
- Publication number
- HRP20090393T1 HRP20090393T1 HR20090393T HRP20090393T HRP20090393T1 HR P20090393 T1 HRP20090393 T1 HR P20090393T1 HR 20090393 T HR20090393 T HR 20090393T HR P20090393 T HRP20090393 T HR P20090393T HR P20090393 T1 HRP20090393 T1 HR P20090393T1
- Authority
- HR
- Croatia
- Prior art keywords
- carboxamide
- carboxamide derivative
- pharmaceutical composition
- oral administration
- pyrazol
- Prior art date
Links
- BNYCHCAYYYRJSH-UHFFFAOYSA-N 1h-pyrazole-5-carboxamide Chemical class NC(=O)C1=CC=NN1 BNYCHCAYYYRJSH-UHFFFAOYSA-N 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- HMXDWDSNPRNUKI-UHFFFAOYSA-N 5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-3-pyrazolecarboxamide Chemical compound CCC=1C(C(=O)NN2CCCCC2)=NN(C=2C(=CC(Cl)=CC=2)Cl)C=1C1=CC=C(Br)C=C1 HMXDWDSNPRNUKI-UHFFFAOYSA-N 0.000 abstract 1
- 239000012736 aqueous medium Substances 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002736 nonionic surfactant Substances 0.000 abstract 1
- JZCPYUJPEARBJL-UHFFFAOYSA-N rimonabant Chemical compound CC=1C(C(=O)NN2CCCCC2)=NN(C=2C(=CC(Cl)=CC=2)Cl)C=1C1=CC=C(Cl)C=C1 JZCPYUJPEARBJL-UHFFFAOYSA-N 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0313259A FR2861992B1 (fr) | 2003-11-10 | 2003-11-10 | Composition pharmaceutique destinee a l'administration orale d'un derive de pyrazole-3-carboxamide. |
| PCT/FR2004/002875 WO2005046690A1 (fr) | 2003-11-10 | 2004-11-09 | Composition pharmaceutique destinee a l'administration orale d'un derive de pyrazole-3carboxamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20090393T1 true HRP20090393T1 (en) | 2009-08-31 |
Family
ID=34508418
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20090393T HRP20090393T1 (en) | 2003-11-10 | 2009-07-10 | Pharmaceutical composition for oral administration of a pyrazol-3-carboxamide derivative |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US20060264469A1 (ru) |
| EP (1) | EP1691808B1 (ru) |
| JP (1) | JP4767171B2 (ru) |
| KR (1) | KR20060108668A (ru) |
| CN (1) | CN100528158C (ru) |
| AR (1) | AR047237A1 (ru) |
| AT (1) | ATE429227T1 (ru) |
| AU (1) | AU2004289086A1 (ru) |
| BR (1) | BRPI0416341A (ru) |
| CA (1) | CA2544413A1 (ru) |
| CY (1) | CY1110478T1 (ru) |
| DE (1) | DE602004020797D1 (ru) |
| DK (1) | DK1691808T3 (ru) |
| ES (1) | ES2325373T3 (ru) |
| FR (1) | FR2861992B1 (ru) |
| HK (1) | HK1102021A1 (ru) |
| HR (1) | HRP20090393T1 (ru) |
| IL (1) | IL175556A (ru) |
| MA (1) | MA28419B1 (ru) |
| NO (1) | NO20062609L (ru) |
| NZ (1) | NZ547763A (ru) |
| PL (1) | PL1691808T3 (ru) |
| PT (1) | PT1691808E (ru) |
| RU (1) | RU2321404C1 (ru) |
| SI (1) | SI1691808T1 (ru) |
| TW (1) | TWI280129B (ru) |
| WO (1) | WO2005046690A1 (ru) |
| ZA (1) | ZA200604451B (ru) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1880715A1 (en) | 2006-07-19 | 2008-01-23 | Abbott GmbH & Co. KG | Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same |
| EP1920767A1 (en) * | 2006-11-09 | 2008-05-14 | Abbott GmbH & Co. KG | Melt-processed imatinib dosage form |
| CA2697328C (en) * | 2007-08-21 | 2015-08-11 | Basilea Pharmaceutica Ag | Antifungal composition |
| MY158809A (en) * | 2010-09-22 | 2016-11-15 | Craun Res Sdn Bhd | Pharmaceutical compositions for calanolides, their derivatives and analogues, and process for producing the same |
| WO2012071043A1 (en) * | 2010-11-24 | 2012-05-31 | Pharmaceutics International, Inc. | Self micro-emulsifying drug delivery system with increased bioavailability |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5059691A (en) * | 1990-01-22 | 1991-10-22 | American Cyanamid Company | N-((dialkylamino)methylene)-substituted pyrazolo (1,5-A)-pyrimidine-3-carboxamides and N-((dialkylamino)methylene)-substituted-4,5-dihydropyrazolo-(1,5-A)-pyrimidine-3-carboxamides |
| FR2692575B1 (fr) * | 1992-06-23 | 1995-06-30 | Sanofi Elf | Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
| SI0649651T1 (en) * | 1993-09-28 | 2001-02-28 | Scherer Gmbh R P | Soft gelatin capsule manufacture |
| GB9405304D0 (en) * | 1994-03-16 | 1994-04-27 | Scherer Ltd R P | Delivery systems for hydrophobic drugs |
| WO1996033697A1 (fr) * | 1995-04-24 | 1996-10-31 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Formulation auto-emulsionnable formant une emulsion huile dans l'eau |
| CA2221145A1 (en) * | 1995-05-19 | 1996-11-21 | Abbott Laboratories | Self-emulsifying formulations of lipophilic drugs |
| US5993858A (en) * | 1996-06-14 | 1999-11-30 | Port Systems L.L.C. | Method and formulation for increasing the bioavailability of poorly water-soluble drugs |
| ID23177A (id) * | 1997-03-14 | 2000-03-23 | Otsuka Pharma Co Ltd | Turunan pirimidin baru |
| FR2761265B1 (fr) * | 1997-03-28 | 1999-07-02 | Sanofi Sa | Composition pharmaceutique pour l'administration orale d'un derive du n-piperidino-3-pyrazolecarboxamide, de ses sels et de leurs solvates |
| FR2761266B1 (fr) * | 1997-03-28 | 1999-07-02 | Sanofi Sa | Composition pharmaceutique formee par granulation humide pour l'administration orale d'un derive du n-piperidino-3- pyrazolecarboxamide, de ses sels et de leurs solvates |
| US6617426B1 (en) * | 1999-06-22 | 2003-09-09 | Merck & Co Inc | Cysteinyl protease inhibitors |
| JP2001151669A (ja) * | 1999-11-24 | 2001-06-05 | Nippon Kayaku Co Ltd | 経口用自己乳化製剤 |
| CA2395331C (en) * | 1999-12-23 | 2009-01-06 | Pfizer Products Inc. | Pharmaceutical compositions providing enhanced drug concentrations |
| GB0001928D0 (en) * | 2000-01-27 | 2000-03-22 | Novartis Ag | Organic compounds |
| FR2831883B1 (fr) * | 2001-11-08 | 2004-07-23 | Sanofi Synthelabo | Forme polymorphe du rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant |
| WO2003074027A2 (en) * | 2002-03-01 | 2003-09-12 | Novagali Pharma Sa | Self emulsifying drug delivery systems for poorly soluble drugs |
| GB0216700D0 (en) * | 2002-07-18 | 2002-08-28 | Astrazeneca Ab | Process |
-
2003
- 2003-11-10 FR FR0313259A patent/FR2861992B1/fr not_active Expired - Fee Related
-
2004
- 2004-11-08 TW TW093134037A patent/TWI280129B/zh not_active IP Right Cessation
- 2004-11-08 AR ARP040104109A patent/AR047237A1/es unknown
- 2004-11-09 CA CA002544413A patent/CA2544413A1/fr not_active Abandoned
- 2004-11-09 JP JP2006538894A patent/JP4767171B2/ja not_active Expired - Fee Related
- 2004-11-09 PT PT04805418T patent/PT1691808E/pt unknown
- 2004-11-09 ES ES04805418T patent/ES2325373T3/es active Active
- 2004-11-09 PL PL04805418T patent/PL1691808T3/pl unknown
- 2004-11-09 RU RU2006120447/15A patent/RU2321404C1/ru not_active IP Right Cessation
- 2004-11-09 ZA ZA200604451A patent/ZA200604451B/en unknown
- 2004-11-09 AU AU2004289086A patent/AU2004289086A1/en not_active Abandoned
- 2004-11-09 CN CNB2004800367848A patent/CN100528158C/zh not_active Expired - Fee Related
- 2004-11-09 DK DK04805418T patent/DK1691808T3/da active
- 2004-11-09 NZ NZ547763A patent/NZ547763A/xx unknown
- 2004-11-09 WO PCT/FR2004/002875 patent/WO2005046690A1/fr active Search and Examination
- 2004-11-09 KR KR1020067009010A patent/KR20060108668A/ko not_active Application Discontinuation
- 2004-11-09 EP EP04805418A patent/EP1691808B1/fr active Active
- 2004-11-09 SI SI200431173T patent/SI1691808T1/sl unknown
- 2004-11-09 AT AT04805418T patent/ATE429227T1/de active
- 2004-11-09 BR BRPI0416341-9A patent/BRPI0416341A/pt not_active IP Right Cessation
- 2004-11-09 DE DE602004020797T patent/DE602004020797D1/de active Active
-
2006
- 2006-05-08 US US11/382,111 patent/US20060264469A1/en not_active Abandoned
- 2006-05-08 MA MA29012A patent/MA28419B1/fr unknown
- 2006-05-09 IL IL175556A patent/IL175556A/en not_active IP Right Cessation
- 2006-06-06 NO NO20062609A patent/NO20062609L/no not_active Application Discontinuation
-
2007
- 2007-06-25 HK HK07106763.5A patent/HK1102021A1/xx not_active IP Right Cessation
-
2008
- 2008-09-09 US US12/206,884 patent/US20090004261A1/en not_active Abandoned
-
2009
- 2009-07-10 HR HR20090393T patent/HRP20090393T1/xx unknown
- 2009-07-21 CY CY20091100777T patent/CY1110478T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20090393T1 (en) | Pharmaceutical composition for oral administration of a pyrazol-3-carboxamide derivative | |
| RS49606B (sr) | Farmaceutski preparat derivata n- piperidino-3- pirazolkarboksamida, njegovih soli i njihovih solvata za oralnu administraciju | |
| BG105749A (en) | Pyrazolecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them | |
| BG110386A (en) | USE OF ANTAGONISTS OF CENTRAL RECEPTORS OF CANNABINOIDS FOR THE RECEIPT OF MEDICINAL PRODUCTS TO FACILITATE THE STOPPING OF TOBACCO CONSUMPTION | |
| BRPI0507005A (pt) | compostos, composições farmacêuticas, uso de um composto, e, método de preparo de uma composição farmacêutica | |
| ATE243691T1 (de) | Piridin-2-yl-methylamin-derivate, verfahren zu deren herstellung und ihre verwendung als arzneimittel | |
| CL2008002737A1 (es) | Sal maleato de 5{[4-((3s)-4-{(1r)-2-metoxi-1-[4-(trifluorometil)fenil]etil}-3-metilpiperazin-1-il)-4-metilpiperidin-1-il]carbonil}-4-metilpirimidina; composicion farmaceutica; uso en el tratamiento del vih, rechazo de trasplantes de organos solidos, artritis reumatoide, entre otras; kit (divisional solicitud 1073-00). | |
| PE20010992A1 (es) | Formulacion de liberacion sostenida de un inhibidor de ciclooxigenasa-2 | |
| NO20085077L (no) | Nye forbindelser | |
| NO20026094L (no) | Kondenserte azepinderivater og deres anvendelse som antidiuretiske midler | |
| DE60017582D1 (de) | Tricyclische derivate der pyrazolcarbonsäure, ihre herstellung und sie enthaltende pharmazeutische zubereitungen | |
| MXPA03010640A (es) | Composiciones pesticidas liquidas estables. | |
| CA2390649A1 (en) | 5-aryl-1h-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them | |
| DK1488781T3 (da) | Farvningssammensætning, der omfatter 4,5-diamino-1-(beta-hydroxyethyl)-1H-pyrazol eller 4,5-diamino-1-(beta-methoxyethyl)-1H-pyrazol som oxidationsbase og 6-hydroxyindol som kobler | |
| MA28105A1 (fr) | Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement des dyslipidemies et des maladies associees aux dyslipidemies et/ou a l'obesite | |
| MA28454B1 (fr) | Utilisation d'antagonistes du recepteur cb1 pour preparer une composition utile pour le traitement des maladies hepatiques | |
| CL2004000520A1 (es) | Mezcla herbicida que comprende derivados de 4-[4-metilsulfonil-benzoil]-1-metil-5-hidroxi-1h-pirazol(topramezona), cloquintocet y opcionalmente otro herbicida; composicion herbicida que comprende la mezcla; proceso de preparacion de la composicion y | |
| DK1796461T3 (da) | Flydende plantebeskyttelsesformuleringer, som indeholder diflufenican | |
| RU2007138042A (ru) | Фармацевтические композиции, содержащие в сочетании соединение-антагонист рецепторов каннабиноидов и нейролептическое средство | |
| KR970702254A (ko) | 에테르화합물, 그의 용도 및 그의 제조에 유용한 중간체(ether compound, use thereof, and intermediate for producing the compound) | |
| MY159418A (en) | New derivatives of flavones, their preparation process, their use as medicaments, pharmaceutical compositions and new use | |
| DK1351942T3 (da) | Nye 2,3-benzodiazepinderivater og farmaceutiske sammensætninger indeholdende disse som den aktive bestanddel | |
| AR061541A1 (es) | Composiciones herbicidas que comprenden un compuesto benzoilico sustituido por 3-heterociclilo | |
| DK1387837T3 (da) | Hidtil ukendte azol- eller triazolderivater, fremgangsmåden til deres fremstilling og deres anvendelse som antimykotiske lægemidler | |
| WO2005010202A3 (en) | PHENYL ACETIC ACID DERIVATIVES AS HEPATOCYTE NUCLEAR FACTOR 4α (HNF-4α) MODULATOR COMPOUNDS |